Amp/Elite Portfolio Strategy Updates Based on Hedge Fund Back-Testing

As a reminder, we are biopharma investors just like you. All of our Elite and Amp portfolios show percent holdings of real money accounts of our co-founder, Manny Vacchiano, JD, PhD. Thus, we are always looking to improve their performance and identify new strategies, including those that are more effective in this current down cycle for biopharma stocks.

Want to read more?

Subscribe to bpiq.com to keep reading this exclusive post.

Subscribe Now